Tag: Flagstaff

Letter to the Editor: F-T Saratoga Sale to Feature 17 Yearlings from Phipps Families

By B. Jason Brooks

The Fasig-Tipton Saratoga Selected Yearling Sale is less than two weeks away and potential buyers are marking up their sales catalogs while researching the accomplished families of those being offered.

At the 2019 Saratoga Sale, four yearlings tracing back to Phipps foundation mare Blitey sold for a collective $4.05 million, one of them being an undefeated Tapit colt named Flightline who has become a multiple Grade I superstar.

Thoroughbred Daily News columnist and pedigree expert Sid Fernando recently noted in story that the Phipps female “families have given past and present breeders a deep foundation on which to build upon and create their own top-class horse.” A look at recent Grade I winners confirms that this is true at the highest levels.

Last year, an impressive 12 Grade I races were won by 10 different horses from families with Phipps female lines, including Aloha West (Hard Spun), Corniche (Quality Road), Essential Quality (Tapit), Flagstaff (Speightstown), Flightline, Golden Pal (Uncle Mo), Maxfield (Street Sense), Bella Sofia (Awesome Patriot), Queen Goddess (Empire Maker) and Got Stormy (Get Stormy), multiple of which are Saratoga Sale graduates.

Through the first seven months of this year, four Grade Is (23 graded stakes wins) have been won by horses from families with Phipps female lines. The Grade I winners this year include Flightline, adding his second Grade I in his first start as a 4-year-old, as well as Shirl's Speight (Speightstown), There Goes Harvard (Will Take Charge) and Matareya (Pioneerof the Nile).

That's an impressive dozen different winners from families with Phipps female lines winning 16 different Grade I races. An exclamation mark added when considering all graded stakes, with 23 of them being won this year by horses from families with Phipps female lines. This level of current success demonstrates the “deep foundation” that Fernando referred to and makes these influential families attractive to breeders and buyers.

A deep dive into the families of the 214 yearlings to be offered at the boutique Saratoga Sale finds that 17, or 8%, are out of top-class mares from families with Phipps female lines, including descendents of Personal Ensign, Blitey, Lady Be Good, Get Lucky, Ten Cents A Dance, and La Troienne mares Belle Histoire and Big Hurry, among others.

On top of their first-rate female families, these blue-blooded yearlings are sired by elite stallions, including Tapit (hips 4 and 179), Curlin (hip 15), Into Mischief (hips 74, 75, 102, 131, 164), Uncle Mo (hips 98, 160, 210), War Front (hip 69), Arrogate (hip 79), Catalina Cruiser (hip 39), Kantharos (hip 211), Oscar Performance (hip 182), and Union Rags (hip 73). Also of note is that Hip 179 is a filly that shares the same sire (Tapit) and Phipps female family (Blitey) as Flightline.

The 2022 Saratoga Sale will provide buyers another chance to purchase yearlings with top-class pedigrees from influential Phipps families which are currently excelling in graded and Grade I races. Like Flightline, some of the yearlings making their way through the sales ring of the Humphrey S. Finney Sales Pavilion in August will become the Thoroughbred stars of tomorrow on the track and subsequently carry on the Phipps legacy in the breeding shed.

The post Letter to the Editor: F-T Saratoga Sale to Feature 17 Yearlings from Phipps Families appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Malibu Moon’s Set Sail Goes Coast to Coast for Maiden Breaking Score

6th-Santa Anita, $67,500, Msw, 3-27, 3yo/up, 1m, 1:37.99, ft, 7 1/2 lengths.

SET SAIL (c, 3, Malibu Moon–Fleet of Gold {SP, $109,892}, by Medaglia d'Oro) was third on debut Feb. 26 in a seven panel maiden over Santa Anita's main track after altering course early and losing second by 1 1/4 lengths. Trying a mile here, the bay Mandella trainee broke on top and never looked back, coasting home much the best by 7 1/2 lengths as the 2-1 second choice over One More Bid (California Chrome). Q B One (Uncle Mo) finished third while 6-5 favorite Bletchley Park (Nyquist) finished a distant fifth.

The winner is the second surviving foal out of the stakes-placed half-sister to Indyan Giving (A.P. Indy), the dam of Champion 2-year-old colt Game Winner (Candy Ride {Arg}) and GI Churchill Downs S. winner Flagstaff (Speightstown). Set Sail has a 2-year-old half-brother by Tapit as well as a 2022 half-sister by Speightstown. Lifetime Record: 2-1-0-1, $48,240.

Click for the Equibase.com chart or VIDEO, sponsored by TVG.

O/B-LNJ Foxwoods; T-Richard E. Mandella.

The post Malibu Moon’s Set Sail Goes Coast to Coast for Maiden Breaking Score appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

CHRB Settlement: John Sadler Fined $5,000 Over 2020 Bisphosphonate Positive

Trainer John Sadler has been fined $5,000 by the California Horse Racing Board, according to a ruling published on Friday, relating to his trainee Flagstaff testing positive for clodronic acid, a bisphosphonate sold under the brand name Osphos, in a post-race sample after finishing second in the Grade 2 Santa Anita Sprint Championship Stakes on Sept. 27, 2020, at Santa Anita Park in Arcadia, Calif.

Bisphosphonates are a class of drug approved by the FDA in 2014 and prescribed to prevent bone loss in people and to treat navicular syndrome in horses, a common cause of forelimb lameness. The drug is not approved for horses less than four years old.

Equine surgeon Dr. Larry Bramlage of Rood & Riddle warned about the use of bisphosphonates Osphos and Tildren in young horses during a client education seminar in 2018, saying the drug can have unintended, detrimental side effects. Many racing states moved to ban the drugs.

The CHRB banned bisphosphonates effective July 1, 2020, saying that any horse administered the drug in the previous six months – effectively a cutoff date of Jan. 1, 2020 – was prohibited from stabling on CHRB regulated grounds.

When the positive test was first made public in May, Sadler's attorney Darrell Vienna said Flagstaff was legally treated with Osphos on an unspecified date “late in 2019,” when Flagstaff was 5 years old. Vienna cited the extended half life of Osphos as an explanation for the positive test, saying it can linger in a horse's system for many months or even longer than a year.

Flagstaff was ordered unplaced in the Santa Anita Sprint Championship by a ruling released on June 19, 2021.

Friday's ruling specifies that Sadler entered into a settlement agreement with the CHRB, and that the fine is for violation of rule #1867.1(b), which states: “No licensee shall bring into a CHRB enclosure a horse known to have been administered a bisphosphonate within the previous six months.”

At the time the positive was announced, clodronic acid was not included on the CHRB's current list of prohibited substances, so under the regulatory body's rules it automatically falls under the most severe drug category, Class 1. Today, current CHRB regulations list bisphosphonates as Drug Class C, Penalty Category A.

Penalty Category A requires a one-year suspension, absent mitigating circumstances, along with a minimum fine of $10,000, again absent mitigating circumstances. Owners face loss of purse and potential placement of a horse on the vet's list for up to 90 days.

The post CHRB Settlement: John Sadler Fined $5,000 Over 2020 Bisphosphonate Positive appeared first on Horse Racing News | Paulick Report.

Source of original post

$5K Bisphosphonate Fine for Sadler

Trainer John Sadler has been fined $5,000 by the Del Mar stewards, and has entered into a settlement agreement and mutual release with the California Horse Racing Board (CHRB), for “knowingly” bringing a horse into a CHRB enclosure “that had been administered bisphosphonates within previous six months,” according to a ruling Friday.

The horse in question–as first reported by the BloodHorse–was GISW sprinter Flagstaff (Speightstown), who was recently retired at the age of seven.

Flagstaff tested positive for the bisphosphonate “clodronate” after finishing second in the 2020 GII Santa Anita Sprint Championship. The Santa Anita stewards subsequently disqualified him, requiring $40,000 in purse monies to be returned, according to a ruling dated June 19 this year.

Bisphosphonates are Food and Drug Administration approved for use in horses 4-year-olds and up for things like osteoarthritis and navicular disease.

But many in the industry have been concerned about the off-label use of these drugs, especially in young horses being prepared for the sales. That's because, rather than strengthening bones as intended, misuse of these drugs could make them weaker, more susceptible to fractures.

These drugs, however, have been notoriously difficult to regulate. Part of the conundrum is that too little is currently known about how long they remain in the horse's system. Bisphosphonates potentially stay in the bone for years.

Too little is also currently known about exactly how they behave for that duration.

As of July 1 last year, the CHRB put into effect a rule broadly prohibiting administration of bisphosphonates to any horse within any CHRB regulated facility. It also prohibits any horse from entering the grounds that has been administered the drug within six months.

Sadler's attorney, Darrell Vienna, stressed that the ruling did not constitute a fine for a medication positive. “If you look at the wording of the actual rule,” he said, “this is not a medication violation.”

The post $5K Bisphosphonate Fine for Sadler appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights